VCYT - Veracyte Inc News Story
$46.91 -8.5 -15.3%
Last Trade - 04/03/21
| Market Cap | £2.26bn |
| Enterprise Value | £2.01bn |
| Revenue | £84.6m |
| Position in Universe | 1752nd / 6647 |
BRIEF-Veracyte Announces De Novo Classification Request To FDA For The Ncounter Dx Lymphmark Assay
Tue 9th June, 2020 1:24pm
June 9 (Reuters) - Veracyte Inc VCYT.O :
* VERACYTE ANNOUNCES DE NOVO CLASSIFICATION REQUEST TO FDA
FOR THE
NCOUNTER DX LYMPHMARK ASSAY
Source text for Eikon: ID:nBw1mNJZka
Further company coverage: VCYT.O
((Reuters Messaging: Reuters.Briefs@thomsonreuters.com))
Recent news on Veracyte Inc
See all news
